Source: Journal of Periodontology. Unidade: FO
Subjects: DEFEITOS DA FURCA, PERIODONTITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ETO, Ana L et al. Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of class II furcation defects: a clinical and radiographic study in humans. Journal of Periodontology, v. 78, n. 12, p. 2277-2283, 2007Tradução . . Acesso em: 02 maio 2024.APA
Eto, A. L., Joly, J. C., Jeffcoat, M., Araújo, N. S. de, Araujo, V. C. de, & Cury, P. R. (2007). Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of class II furcation defects: a clinical and radiographic study in humans. Journal of Periodontology, 78( 12), 2277-2283.NLM
Eto AL, Joly JC, Jeffcoat M, Araújo NS de, Araujo VC de, Cury PR. Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of class II furcation defects: a clinical and radiographic study in humans. Journal of Periodontology. 2007 ; 78( 12): 2277-2283.[citado 2024 maio 02 ]Vancouver
Eto AL, Joly JC, Jeffcoat M, Araújo NS de, Araujo VC de, Cury PR. Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of class II furcation defects: a clinical and radiographic study in humans. Journal of Periodontology. 2007 ; 78( 12): 2277-2283.[citado 2024 maio 02 ]
